Aspen Aerogels, Inc. (NYSE: ASPN) is a Basic Materials company (Chemicals - Specialty) with a market capitalization of $407M. The Maz Rating grades it against the other companies in its sector.
About three months ago (August 17, 2026), Aspen Aerogels, Inc. had a Maz Rating of 3.22 out of 5 (B+, Buy), ranked against the other companies in its sector. Its strongest factor then was Momentum (4.05), above most of its sector; its weakest was Growth (1.54), below most of its sector. The other factors: Financial Health 3.17 (around the middle of its sector); Valuation 2.82 (valued in line with its sector); Profitability 2.61 (around the middle of its sector). The current rating is for members: log in to see it.
At $4.90, Aspen Aerogels, Inc. trades at 1.9x sales and 2.2x book value. Over the last twelve months it generated about $213M of revenue and a net loss of $131M. It runs a gross margin of 2.4%, an operating margin of -44.3% and a net margin of -60.8%. It shows return on equity of -63.1%, return on invested capital of -31.0% and a free cash flow yield of 4.9%. On the balance sheet: a debt-to-equity ratio of 0.57 and a current ratio of 2.10. Over the past 52 weeks the share price ranged from $2.30 to $8.10, with a beta of 3.07.
Aspen Aerogels, Inc. does not currently pay a dividend.
23 Wall Street analyst ratings cover the stock: 19 Buy, 3 Hold and 1 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.